Does Dr. SYED AHMED have financial conflicts of interest?

Dr. SYED AHMED (MD) has received a total of $122 in pharmaceutical and medical device industry funding between 2021 and 2024. This includes $122 in personal promotional payouts (consulting, meals, travel) and $0 in clinical research grants. Financial ties do not automatically imply conflict of interest, but are disclosed under the Sunshine Act.

Which pharmaceutical companies pay Dr. SYED AHMED?

According to CMS Open Payments data, Dr. SYED AHMED received funding from BOEHRINGER INGELHEIM PHARMACEUTICALS ($33), NOVARTIS PHARMACEUTICALS CORPORATION ($31), and ABBOTT LABORATORIES ($17).

Does Dr. SYED AHMED receive research grants or speaking fees?

Dr. SYED AHMED has received $122 in general promotional payments (such as consulting honoraria, meals, and speaking fees) and $0 in clinical research grants.

DR. SYED AHMED

MDReal-Time Hydrated

Specialty: Internal Medicine, Cardiovascular Disease

Practice Location: MONTGOMERY, OH 45242

NPI Number: 1336264860

LIFETIME INDUSTRY VALUE

$122

2021 – 2024 Cumulative

Conflict of Interest Analysis

Dr. AHMED is a verified Internal Medicine, Cardiovascular Disease practitioner based in MONTGOMERY, OH.

Between 2021 and 2024, Dr. AHMED had an overall industry promotional and research financial footprint of $122 as recorded in the federal CMS Open Payments database.

$122 was received in general payments, which include consultation fees, travel expenses, honoraria, and sponsored meals.
$0 was allocated to sponsored clinical trials and medical research activities.

Dr. AHMED's primary funding source is BOEHRINGER INGELHEIM PHARMACEUTICALS, which accounts for $33 (representing 27.3% of overall industry footprint).

Data coverage: 2021 – 2024 · Source: CMS Open Payments · CMS publishes each year's data around June 30 of the following year.

Payout Trend Over Time

General Payments

Research Funding

Top Funding Entities

Pharmaceutical & Device Manufacturers making direct payments

BOEHRINGER INGELHEIM PHARMACEUTICALS

Rank 1

$33

27.3%

NOVARTIS PHARMACEUTICALS CORPORATION

Rank 2

$31

25%

ABBOTT LABORATORIES

Rank 3

$17

13.7%

Itemized Transaction Archives

Direct live query to Socrata CMS Open Payments API (Bypasses local DB)

Year:

2024

Filter < $250

Click "Load Live Logs" to query the federal Open Payments registry directly.

Frequently Asked Questions

Answers compiled using federal transparency disclosure records under the Sunshine Act.